Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts shared comment.

Flovent, one of the most commonly prescribed asthma medications, is no longer being manufactured. Parents share their thoughts on alternatives. Hotspots ranked Start the day smarter ☀️ ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

Respiratory Inhalers Patent Landscape Market Respiratory Inhalers Patent Landscape Market Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Inhalers Patent Landscape Report and Forecast ...

Lower respiratory infections can also be treated at home with rest, fluids, and over-the-counter medications. In addition, you may need a bronchodilator inhaler if you are wheezing and short of ...

The respiratory inhaler devices market is a critical component of the global healthcare industry, focusing on devices designed to deliver medication directly to the lungs to treat respiratory diseases ...

Respiratory diseases are a major cause of health problems around the world. The most common include COPD, asthma, and obstructive sleep apnea.

Expert opinion from Dr. Anuvitha Kamath MBBS · 3 years of experience · India. S ome of the practices for prevention of ...

Flovent, one of the most commonly prescribed childhood asthma medications, is no longer being manufactured in the United States. GSK, the pharmaceutical company that made it, took if off the ...

"You have the same medications, two different delivery systems," Divo says. Climate impact of metered-dose inhalers vs. cars . Patients in the United States are prescribed roughly 144 million of ...

Flovent, one of the most commonly prescribed childhood asthma medications, is no longer being manufactured in the United States. GSK, the pharmaceutical company that made it, took if off the ...